CYCN - Cyclerion announces 1 for 20 reverse stock split
2023-05-15 13:49:08 ET
- Cyclerion Therapeutics ( NASDAQ: CYCN ) announced a reverse stock split of its outstanding common shares at a ratio of 1-for-20, effective as of 5:00 p.m. ET on May 15, 2023.
- The reverse stock split was approved by the Company’s stockholders at its annual meeting of stockholders held on May 15, 2023, with the final ratio determined by the Company’s board of directors.
- Outstanding equity-based awards and other outstanding equity rights will be proportionately adjusted.
- Immediately after the reverse stock split becomes effective, there will be approximately 2,176,244 shares of common stock issued and outstanding.
- CYCN is -12.3% to $0.1956
- Source: Press Release
For further details see:
Cyclerion announces 1 for 20 reverse stock split